Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 303

1.

Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.

Valenstein M, Ganoczy D, McCarthy JF, Myra Kim H, Lee TA, Blow FC.

J Clin Psychiatry. 2006 Oct;67(10):1542-50.

PMID:
17107245
2.

Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.

Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T.

Schizophr Bull. 2004;30(2):255-64.

PMID:
15279044
3.

Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.

Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T.

Med Care. 2002 Aug;40(8):630-9.

PMID:
12187177
4.

Factors related to antipsychotic oversupply among Central Texas Veterans.

Yang M, Barner JC, Worchel J.

Clin Ther. 2007 Jun;29(6):1214-25.

PMID:
17692735
5.

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.

Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW.

J Clin Psychiatry. 2006 Mar;67(3):453-60.

PMID:
16649833
6.

[Relationships between insight and medication adherence in subjects with psychosis].

Droulout T, Liraud F, Verdoux H.

Encephale. 2003 Sep-Oct;29(5):430-7. French.

PMID:
14615692
7.

A pilot study of barriers to medication adherence in schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G.

J Clin Psychiatry. 2004 Feb;65(2):211-6.

PMID:
15003075
8.

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR.

J Clin Psychiatry. 2006 Jul;67(7):1114-23.

PMID:
16889456
9.

Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.

Valenstein M, Copeland LA, Owen R, Blow FC, Visnic S.

J Clin Psychiatry. 2001 Jul;62(7):545-51.

PMID:
11488366
10.

Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia.

Cooper D, Moisan J, Grégoire JP.

J Clin Psychiatry. 2007 Jun;68(6):818-25.

PMID:
17592904
11.

Substance abuse and the management of medication nonadherence in schizophrenia.

Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.

J Nerv Ment Dis. 2006 Jun;194(6):454-7.

PMID:
16772865
12.
14.

Treatment adherence with antipsychotic medications in bipolar disorder.

Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV.

Bipolar Disord. 2006 Jun;8(3):232-41.

15.

Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.

Fujikawa M, Togo T, Yoshimi A, Fujita J, Nomoto M, Kamijo A, Amagai T, Uchikado H, Katsuse O, Hosojima H, Sakura Y, Furusho R, Suda A, Yamaguchi T, Hori T, Kamada A, Kondo T, Ito M, Odawara T, Hirayasu Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):755-60. doi: 10.1016/j.pnpbp.2007.12.002. Epub 2007 Dec 14.

PMID:
18226436
16.
18.

Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.

Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman J, Schene A, Nosè M, Helm H, Thornicroft G, Tansella M.

Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973. Epub 2009 Aug 11.

PMID:
19672133
19.

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration.

Shi L, Ascher-Svanum H, Chiang YJ, Zhao Y, Fonseca V, Winstead D.

BMC Psychiatry. 2009 Dec 18;9:80. doi: 10.1186/1471-244X-9-80.

20.

Clinical correlates of early medication adherence: West London first episode schizophrenia study.

Mutsatsa SH, Joyce EM, Hutton SB, Webb E, Gibbins H, Paul S, Barnes TR.

Acta Psychiatr Scand. 2003 Dec;108(6):439-46.

PMID:
14616225

Supplemental Content

Support Center